150 related articles for article (PubMed ID: 29903521)
21. Integrin-linked kinase: a cancer therapeutic target unique among its ILK.
Hannigan G; Troussard AA; Dedhar S
Nat Rev Cancer; 2005 Jan; 5(1):51-63. PubMed ID: 15630415
[TBL] [Abstract][Full Text] [Related]
22. Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor.
Kaneko Y; Kitazato K; Basaki Y
J Cell Sci; 2004 Jan; 117(Pt 3):407-15. PubMed ID: 14679308
[TBL] [Abstract][Full Text] [Related]
23. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
24. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
[TBL] [Abstract][Full Text] [Related]
25. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
[TBL] [Abstract][Full Text] [Related]
26. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
27. The integrin-linked kinase (ILK) suppresses anoikis.
Attwell S; Roskelley C; Dedhar S
Oncogene; 2000 Aug; 19(33):3811-5. PubMed ID: 10949937
[TBL] [Abstract][Full Text] [Related]
28. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
[TBL] [Abstract][Full Text] [Related]
29. Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis.
Gkretsi V; Mars WM; Bowen WC; Barua L; Yang Y; Guo L; St-Arnaud R; Dedhar S; Wu C; Michalopoulos GK
Hepatology; 2007 Apr; 45(4):1025-34. PubMed ID: 17385211
[TBL] [Abstract][Full Text] [Related]
30. Integrin linked kinase (ILK) expression and function in vascular smooth muscle cells.
Ho B; Bendeck MP
Cell Adh Migr; 2009; 3(2):174-6. PubMed ID: 19262169
[TBL] [Abstract][Full Text] [Related]
31. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation.
Fouladi F; Jehn LB; Metzelder SK; Hub F; Henkenius K; Burchert A; Brendel C; Stiewe T; Neubauer A
Leuk Lymphoma; 2015; 56(9):2690-8. PubMed ID: 25665465
[TBL] [Abstract][Full Text] [Related]
33. Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells.
El Kharbili M; Robert C; Witkowski T; Danty-Berger E; Barbollat-Boutrand L; Masse I; Gadot N; de la Fouchardière A; McDonald PC; Dedhar S; Le Naour F; Degoul F; Berthier-Vergnes O
Oncotarget; 2017 Mar; 8(10):17140-17155. PubMed ID: 28188308
[TBL] [Abstract][Full Text] [Related]
34. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
35. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.
Brenner AK; Andersson Tvedt TH; Bruserud Ø
Molecules; 2016 Nov; 21(11):. PubMed ID: 27845732
[TBL] [Abstract][Full Text] [Related]
36. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
37. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
[TBL] [Abstract][Full Text] [Related]
38. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
Martelli AM; Evangelisti C; Chiarini F; Grimaldi C; Manzoli L; McCubrey JA
Expert Opin Investig Drugs; 2009 Sep; 18(9):1333-49. PubMed ID: 19678801
[TBL] [Abstract][Full Text] [Related]
39. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
Ghosh J; Kapur R
Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
[TBL] [Abstract][Full Text] [Related]
40. Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.
Cianfrocca R; Rosanò L; Spinella F; Di Castro V; Natali PG; Bagnato A
Can J Physiol Pharmacol; 2010 Aug; 88(8):796-801. PubMed ID: 20725137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
